Rafferty Asset Management, LLC Catalent, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 25,715 shares of CTLT stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,715

Previous 26,953 4.59%

Holding current value

$1.63 Million

Previous $1.52 Million 2.77%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $69,526 - $75,468	-1,238 Reduced 4.59%	25,715 $1.56 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $367,183 - $390,758	-6,853 Reduced 20.27%	26,953 $1.52 Million
Q1 2024 May 13, 2024	SELL	$42.56 - $59.82 $238,846 - $335,709	-5,612 Reduced 14.24%	33,806 $1.91 Million
Q4 2023 Feb 13, 2024	BUY	$32.18 - $46.57 $138,341 - $200,204	4,299 Added 12.24%	39,418 $1.77 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $2,696 - $3,062	61 Added 0.17%	35,119 $1.6 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $280,814 - $592,829	8,814 Added 33.58%	35,058 $1.52 Million
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $189,030 - $308,921	4,160 Added 18.84%	26,244 $1.72 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $410,837 - $804,006	9,926 Added 81.64%	22,084 $993,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $404,347 - $632,002	5,588 Added 85.05%	12,158 $880,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $300,752 - $393,358	-3,449 Reduced 34.42%	6,570 $705,000
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $265,144 - $350,439	-2,815 Reduced 21.93%	10,019 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $219,410 - $255,193	1,835 Added 16.68%	12,834 $1.64 Million
Q3 2021 Nov 10, 2021	BUY	$109.17 - $142.35 $311,789 - $406,551	2,856 Added 35.07%	10,999 $1.46 Million
Q2 2021 Aug 10, 2021	BUY	$100.34 - $115.69 $131,646 - $151,785	1,312 Added 19.21%	8,143 $880,000
Q1 2021 May 10, 2021	SELL	$101.51 - $125.27 $97,652 - $120,509	-962 Reduced 12.34%	6,831 $719,000
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $21,555 - $26,445	251 Added 3.33%	7,793 $811,000
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $225,566 - $286,842	3,101 Added 69.83%	7,542 $646,000
Q2 2020 Aug 07, 2020	BUY	$48.02 - $79.04 $213,256 - $351,016	4,441 New	4,441 $326,000
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $260,423 - $443,671	-7,048 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$47.06 - $56.64 $131,203 - $157,912	-2,788 Reduced 28.34%	7,048 $397,000
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $466,718 - $570,979	9,836 New	9,836 $469,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Catalent, Inc. Transaction History